Cargando…
The wisdom in ISCHEMIA
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) study was published recently demonstrating that over a period of 3.3 years a routine invasive approach along with optimised medical therapy (OMT) was not superior to OMT alone in patients with...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772578/ https://www.ncbi.nlm.nih.gov/pubmed/33357658 http://dx.doi.org/10.1016/j.ihj.2020.11.001 |
_version_ | 1783629902354841600 |
---|---|
author | Thomas, Boban Hassan, Imad |
author_facet | Thomas, Boban Hassan, Imad |
author_sort | Thomas, Boban |
collection | PubMed |
description | The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) study was published recently demonstrating that over a period of 3.3 years a routine invasive approach along with optimised medical therapy (OMT) was not superior to OMT alone in patients with stable coronary artery disease and at least moderate to severe ischemia. Considerable interest and discussion have emerged over the applicability of the trial to real-world settings and the limitations of the trial. Given the fact that no clinical trial will ever be designed that will be perfect, it is important to prise out the pearls that the findings reveal and not interpret the findings as either positive or negative towards one approach or the other. |
format | Online Article Text |
id | pubmed-7772578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-77725782020-12-30 The wisdom in ISCHEMIA Thomas, Boban Hassan, Imad Indian Heart J Opinion Paper The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) study was published recently demonstrating that over a period of 3.3 years a routine invasive approach along with optimised medical therapy (OMT) was not superior to OMT alone in patients with stable coronary artery disease and at least moderate to severe ischemia. Considerable interest and discussion have emerged over the applicability of the trial to real-world settings and the limitations of the trial. Given the fact that no clinical trial will ever be designed that will be perfect, it is important to prise out the pearls that the findings reveal and not interpret the findings as either positive or negative towards one approach or the other. Elsevier 2020 2020-11-06 /pmc/articles/PMC7772578/ /pubmed/33357658 http://dx.doi.org/10.1016/j.ihj.2020.11.001 Text en © 2020 Cardiological Society of India. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Opinion Paper Thomas, Boban Hassan, Imad The wisdom in ISCHEMIA |
title | The wisdom in ISCHEMIA |
title_full | The wisdom in ISCHEMIA |
title_fullStr | The wisdom in ISCHEMIA |
title_full_unstemmed | The wisdom in ISCHEMIA |
title_short | The wisdom in ISCHEMIA |
title_sort | wisdom in ischemia |
topic | Opinion Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772578/ https://www.ncbi.nlm.nih.gov/pubmed/33357658 http://dx.doi.org/10.1016/j.ihj.2020.11.001 |
work_keys_str_mv | AT thomasboban thewisdominischemia AT hassanimad thewisdominischemia AT thomasboban wisdominischemia AT hassanimad wisdominischemia |